In addition to the finding that MCPIP1 promotes apoptosis and inhibits cervical cancer progression in vivo and in vitro, our study found that the targeted delivery of exogenous MCPIP1 with engineered S. typhimurium showed significant inhibition of HeLa tumor growth. Here, ZC3H12A is linked to cervical cancer.